Levothyroxine Sodium Tablets — Class II drug recall D-104-2013
Terminated recall by Alara Pharmaceutical Co, reported 2013-01-02, distributed nationwide. Subpotent; 15 month stability
| Recall number | D-104-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Alara Pharmaceutical Co, San Juan, PR, United States |
| Recall initiated | 2012-10-29 |
| Classified | 2012-12-21 |
| Reported by FDA | 2013-01-02 |
| Terminated | 2014-01-03 |
| Distributed | Nationwide (US) |
| Quantity | 7,432 bottles |
| Reason classes | potency, specification failure |
| Expiration dates | 2012-12 |
Product
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
Reason for recall
Subpotent; 15 month stability
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-104-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.